Eximis Surgical has filed a notice of an exempt offering of securities to raise $8,742,615.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Eximis Surgical is raising $8,742,615.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Donna Ford-Serbu played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Eximis Surgical
Eximis Surgical Inc., develops innovative technologies for the removal of large specimens during minimally invasive procedures. The company is in the pre-market phase and is actively working towards FDA submission for its first device in the platform. Eximis Surgical proprietary technology is designed to provide surgeons a fully automated and contained system that leverages controlled RF energy delivery to segment large tissue specimens for removal through a small incision.
To learn more about Eximis Surgical, visit http://www.eximissurgical.com/
Contact:
Donna Ford-Serbu, Chief Executive Officer
720-890-1111
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.